跳至主要内容
临床试验/NL-OMON48801
NL-OMON48801招募中2 期

eo-adjuvant versus Adjuvant chemotherapy in Upper Tract Urothelial Carcinoma: A feasibility phase II randomized clinical trial (*URANUS*) - URANUS

eids Universitair Medisch Centrum0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Histological and radiological defined UTUC: Histologically-confirmed diagnosis
  • of predominantly urothelial carcinoma of the upper urinary tract
  • Patients with UTUC cT2-cT4 cN0-N1 M0 (TNM classification)
  • Patients without bladder cancer or with concomitant non muscle invasive bladder
  • Adequate organ system function
  • CT scan of the chest, abdomen and pelvis and bone scan without evidence of
  • distant metastasis

排除标准

  • Histology of pure adenocarcinoma, pure squamous cell carcinoma, sarcomatoid or
  • predominant small cell carcinoma.
  • Any major contraindication to a surgical procedure.
  • Other active neoplasms.
  • Concomitant muscle invasive bladder cancer.

研究者

相似试验

eo-adjuvant versus Adjuvant chemotherapy in Upper... | 临床试验